drugset / Trial / NCT07709520
Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
RandomizedParallel-groupTriple-blindTreatment
Summary
A randomized, double-blind, placebo-controlled Phase IIa clinical study to evaluate the safety and efficacy of GST-HG131/GST-HG141 tablets in patients with chronic hepatitis B
Timeline
- Start
- 2026-07-10
- Primary completion
- 2026-10-01
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neracorvir | Other / unclassified | — | — |
| Background | GST-HG131 | Small molecule | — | — |